{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:10Z","timestamp":1786115650386,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Composite cardiometabolic and inflammatory indices can be calculated from routine anthropometric and laboratory measures, but their value for cardiovascular disease (CVD) risk assessment in Chinese populations remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 7,170 participants free of CVD at baseline from the China Health and Retirement Longitudinal Study (CHARLS) and the Shanghai Diabetes Study (SHDS). Mean follow-up was approximately 41 months in both cohorts. The evaluated indices included body mass index (BMI), Chinese visceral adiposity index (CVAI), lipid accumulation product (LAP), triglyceride-glucose index (TyG), atherogenic index of plasma (AIP), high-sensitivity C-reactive protein (hs-CRP), hs-CRP to high-density lipoprotein cholesterol ratio (hs-CRP\/HDL-C), and hs-CRP-glucose index (CTI). Cox proportional hazards models were used to examine associations with incident CVD, with cohort interactions tested to assess cross-cohort consistency. Dose-response and nonlinearity were evaluated using quartile-based analyses and restricted cubic splines. Predictive performance and the added value of each index beyond a common clinical base model were evaluated in terms of clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During follow-up, 343 CVD events occurred in CHARLS and 148 occurred in SHDS. CVAI was the only index consistently associated with incident CVD across both cohorts and adjustment models. In the fully adjusted model, the HR per SD increase in CVAI was 1.221 (95% CI: 1.070\u20131.392,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) in CHARLS, and 1.330 (95% CI: 1.067\u20131.656,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011) in SHDS. Other indices showed cohort-specific patterns: CTI, hs-CRP, and hs-CRP\/HDL-C remained associated with CVD in CHARLS, whereas LAP remained associated across models in SHDS. Quartile-based and spline analyses generally supported approximately linear dose-response patterns. When added to the clinical base model, individual indices produced only modest changes in discrimination, and decision curve net benefit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In two Chinese cohorts, CVAI showed the most reproducible association with short- to mid-term CVD risk, whereas other indices provided more cohort-specific signals. These indices may help describe cardiometabolic risk burden, but their incremental predictive value beyond conventional clinical factors was limited. Further studies with longer follow-up, verified outcomes, and more diverse populations are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1896146","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:31Z","timestamp":1785990331000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative associations and incremental predictive value of cardiometabolic and inflammatory indices for short- to mid-term cardiovascular disease risk in two Chinese cohorts"],"prefix":"10.3389","volume":"13","author":[{"given":"Tumalisi","family":"Julaiti","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Chen","sequence":"additional","affiliation":[{"name":"SenseTime","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Information Technology, Haikou Orthopedic and Diabetes Hospital, Haikou Orthopedic and Diabetes Hospital of Shanghai Sixth People's Hospital","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"SenseTime","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiemin","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/circresaha.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mpdhp.2017.11.009","article-title":"Pathogenesis of atherosclerosis","volume":"23","author":"Wang","year":"2017","journal-title":"Diagn Histopathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1358769","DOI":"10.3389\/fmed.2024.1358769","article-title":"Editorial: pathophysiology, treatment and rehabilitation of atherosclerosis-related diseases in geriatric population","volume":"11","author":"Xu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.3390\/ijms262110683","article-title":"Linking systemic inflammation to coronary lesion complexity: a combined FFR and OCT study","volume":"26","author":"Popa-Fotea","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.3390\/ijms26146855","article-title":"The pathogenic role of C-reactive protein in diabetes-linked unstable atherosclerosis","volume":"26","author":"Sibianu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/nu17081324","article-title":"Lipoprotein(a) and risk of incident atherosclerotic cardiovascular disease: impact of high-sensitivity C-reactive protein and risk variability among human clinical subgroups","volume":"17","author":"Hoogeveen","year":"2025","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/atvbaha.111.241885","article-title":"Insulin resistance and coronary heart disease in nondiabetic individuals","volume":"32","author":"Reaven","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12933-024-02518-2","article-title":"The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort","volume":"23","author":"Yang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13098-023-01181-z","article-title":"Association of triglyceride-glucose index with cardiovascular disease among a general population: a prospective cohort study","volume":"15","author":"Wan","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"38214","DOI":"10.1038\/srep38214","article-title":"A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese","volume":"6","author":"Xia","year":"2016","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))","volume":"34","author":"Dobi\u00e1sov\u00e1","year":"2001","journal-title":"Clin Biochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","article-title":"A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer","volume":"13","author":"Ruan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1467-789X.2002.00071.x","article-title":"Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China","volume":"3","author":"Jia","year":"2002","journal-title":"Obes Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00125-006-0503-1","article-title":"Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai diabetes studies, a cross-sectional 3-year follow-up study in Shanghai urban communities","volume":"50","author":"Jia","year":"2007","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.02.028","article-title":"Serum C-reactive protein and risk of cardiovascular events in middle-aged and older Chinese population","volume":"103","author":"Jiang","year":"2009","journal-title":"Am J Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2017.01745","article-title":"Aging, obesity, and inflammatory age-related diseases","volume":"8","author":"Frasca","year":"2017","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.3390\/jcm14072352","article-title":"Beyond cholesterol: emerging risk factors in atherosclerosis","volume":"14","author":"Bekbossynova","year":"2025","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2775","DOI":"10.1210\/clinem\/dgab049","article-title":"Chinese adults are more susceptible to effects of overall obesity and fat distribution on cardiometabolic risk factors","volume":"106","author":"Zheng","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/diagnostics12102522","article-title":"Visceral obesity and lipid profiles in Chinese adults with normal and high body mass index","volume":"12","author":"Lu","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2472856","DOI":"10.1080\/07853890.2025.2472856","article-title":"Evolving perspectives on evaluating obesity: from traditional methods to cutting-edge techniques","volume":"57","author":"Wang","year":"2025","journal-title":"Ann Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41598-025-31561-6","article-title":"Association between changes in Chinese visceral adiposity index and cardiovascular disease among middle-aged and older Chinese adults","volume":"16","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12889-025-25830-2","article-title":"Weight-adjusted waist index outperforms other obesity indices for cardiovascular disease prediction in cardiovascular-kidney-metabolic syndrome: insights from UK biobank","volume":"26","author":"Wang","year":"2025","journal-title":"BMC Public Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","article-title":"Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts","volume":"24","author":"Huang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/s0140-6736(11)60105-0.","article-title":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies","volume":"377","author":"Wormser","year":"2011","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0240214","DOI":"10.1371\/journal.pone.0240214","article-title":"Waist circumference does not improve established cardiovascular disease risk prediction modeling","volume":"15","author":"Nelms","year":"2020","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1445-5994.2008.01864.x","article-title":"Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study","volume":"39","author":"Barr","year":"2009","journal-title":"Intern Med J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e002334","DOI":"10.1136\/bmjopen-2012-002334","article-title":"Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial","volume":"3","author":"Bolland","year":"2013","journal-title":"BMJ Open"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1896146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:32Z","timestamp":1785990332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1896146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2026.1896146"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1896146","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1896146"}}